human diseases

Randomized Trials Built on Sand: Examples From COPD, Hormone Therapy, and Cancer.

Published August 4, 2013

Randomized Trials Built on Sand: Examples from COPD, Hormone Therapy, and Cancer.

Rambam Maimonides Med J. 2012 Jul; 3(3): e0014
Suissa S

The randomized controlled trial is the fundamental study design to evaluate the effectiveness of medications and receive… Continue reading →

Predicting Self-Initiated Marijuana Use Cessation Among Youth at Continuation High Schools.

Published July 31, 2013

Predicting Self-Initiated Marijuana Use Cessation among Youth at Continuation High Schools.

Front Psychiatry. 2013; 4: 69
Little MA, Spruijt-Metz D, Pokhrel P, Sun P, Rohrbach LA, Sussman S

The current article reports a large scale study of the prediction… Continue reading →

Nutrition Quality of Life Among Female-Majority Malay Undergraduate Students of Health Sciences.

Published June 21, 2013

Nutrition Quality of Life among Female-Majority Malay Undergraduate Students of Health Sciences.

Malays J Med Sci. 2012 Oct; 19(4): 37-49
Pei Lin L, Wan Putri Elena WD, Mohd Razif S

University students generally tend to engage in problematic eating… Continue reading →

Correction: Risky Food Safety Behaviors Are Associated With Higher BMI and Lower Healthy Eating Self-Efficacy and Intentions Among African American Churchgoers in Baltimore.

Published June 7, 2013

Correction: Risky Food Safety Behaviors Are Associated with Higher BMI and Lower Healthy Eating Self-Efficacy and Intentions among African American Churchgoers in Baltimore.

PLoS One. 2013; 8(5):
Anderson Steeves E, Silbergeld E, Summers A, Chen L, Gittelsohn J

[This… Continue reading →

PET Radiopharmaceuticals for Probing Enzymes in the Brain.

Published May 3, 2013

PET radiopharmaceuticals for probing enzymes in the brain.

Am J Nucl Med Mol Imaging. 2013; 3(3): 194-216
Holland JP, Cumming P, Vasdev N

Biologically important processes in normal brain function and brain disease involve the action of various protein-based… Continue reading →

Substance Use Disorders: Psychoneuroimmunological Mechanisms and New Targets for Therapy.

Published May 3, 2013

Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy.

Pharmacol Ther. 2013 Apr 27;
Loftis JM, Huckans M

An estimated 76.4 million people worldwide meet criteria for alcohol use disorders, and 15.3 million meet criteria for drug use… Continue reading →

[Gambling Addiction.]

Published March 27, 2013

[Gambling addiction.]

Nervenarzt. 2013 Mar 27;
Böning J, Meyer G, Hayer T

Extensive coherent clinical, psychopathological, neurobiological and genetic similarities with substance-related addictions justify the forthcoming classification of gambling addiction under the new category “Substance Use and Addictive Disorders”… Continue reading →

Conceptual Framework for Research and Clinical Practice Concerning Cardiovascular Health-Related Behaviors.

Published March 15, 2013

Conceptual framework for research and clinical practice concerning cardiovascular health-related behaviors.

Rev Lat Am Enfermagem. 2013 Feb; 21 Spec No: 207-15
Gallani MC, Cornélio ME, Agondi Rde F, Rodrigues RC

To present a conceptual framework based on the PRECEDE… Continue reading →

The Μ Opioid Receptor and Ligands Acting at the Μ Opioid Receptor, as Therapeutics and Potential Therapeutics.

Published March 2, 2013

The µ Opioid Receptor and Ligands Acting at the µ Opioid Receptor, as Therapeutics and Potential Therapeutics.

Curr Pharm Des. 2013 Feb 20;
Spetea M, Asim MF, Wolber G, Schmidhammer H

Although the µ opioid receptor (MOR) was pharmacologically… Continue reading →

Neurobehavioral and Genotoxic Evaluation of (-)-Linalool in Mice.

Published February 27, 2013

Neurobehavioral and genotoxic evaluation of (-)-linalool in mice.

J Nat Med. 2013 Feb 24;
Coelho V, Mazzardo-Martins L, Martins DF, Santos AR, da Silva Brum LF, Picada JN, Pereira P

(-)-Linalool is a monoterpene compound commonly found as a… Continue reading →